The Real-world Treatment Satisfaction by Gefapixiant in RCC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Real-world Treatment Satisfaction by Gefapixiant in RCC — Stella

Home/Chronic Cough/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Cough trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Japan

Nagoya City University, Nagoya, Aichi-ken

Nagoya City University Hospital, Nagoya, Aichi-ken

Key details

Sponsor

Nagoya City University

Collaborators

Merck Sharp & Dohme LLC

Enrollment target

~63 participants

Started

December 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.